newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth

ZURICH, SWITZERLAND , July 24, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in the design and development of next-generation cancer therapeutics, held an